Decision is a setback for Dr. Reddy’s Laboratories, which was poised to be one of the first generic competitors to Ozempic ...

Dr Reddy's Labs may face an 8-12 month delay in launching its semaglutide generic in Canada after receiving a non-compliance ...

For many, losing weight through diet, exercise and lifestyle changes alone can be frustratingly limited. Today, GLP-1 ...

Questions are swirling around the use of semaglutide, commonly sold under the brand name Ozempic, for weight loss. CBC’s ...

Firm Novo Nordisk’s global patent is set to expire in parts of the world from early 2026, allowing cut-price ‘own-label’ versions of Wegovy and Ozempic to be sold, according to reports ...

Shares of Indian generic drugmaker Dr Reddy's Laboratories declined more than 5% on Thursday, after the firm received a non-compliance notice for its semaglutide injection in Canada, which analysts ...

(Reuters) -Canada has approved Novo Nordisk's diabetes drug, Ozempic, to cut chronic kidney disease progression and reduce the risk of kidney failure and heart-related deaths in type-2 diabetes ...

A new oral weight loss medication, orforglipron, demonstrated meaningful weight loss results in phase 3 trials, potentially ...

Health Canada on Tuesday approved Novo Nordisk's (NYSE:NVO) Ozempic (semaglutide) to reduce the risk of kidney disease and cardiovascular deaths in adults with type 2 diabetes. The approval makes ...

Can you breastfeed while taking semaglutide? Doctors explain if it's safe to take GLP-1 drugs such as Ozempic and Wegovy for ...